Skip to main content
. 2016 Jun 11;32(5):733–741. doi: 10.1007/s00467-016-3399-0

Table 3.

Disease onset and diagnosis of cobalamin C (cblC) and complement data: findings in 36 patients with cblC defect and thrombotic microangiopathy

 Variables  Findings
cblC defect
 Biochemical 94 % (n = 34/36)
 Genetic 50 % (n = 18/36)
Mutations (allelic frequency)
 c.271dupA 36 % (n = 13/36)
 c.276G>T 17 % (n = 6/36)
 c.565C>A 11 % (n = 4/36)
Complement system
Normal 87 % (n = 13/15)
 CFH-autoantibodies 6.6 % (n = 1/15)
CFH mutation 6.6 % (n = 1/15)